0001786717-25-000002.txt : 20251117 0001786717-25-000002.hdr.sgml : 20251117 20251117165647 ACCESSION NUMBER: 0001786717-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251117 DATE AS OF CHANGE: 20251117 EFFECTIVENESS DATE: 20251117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Qlaris Bio, Inc. CENTRAL INDEX KEY: 0001786717 ORGANIZATION NAME: EIN: 823855491 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-564231 FILM NUMBER: 251491699 BUSINESS ADDRESS: STREET 1: ONE MAIN STREET, SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 201-294-7644 MAIL ADDRESS: STREET 1: ONE MAIN STREET, SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001786717 Qlaris Bio, Inc. 770 Legacy Place 2nd Floor Dedham MA MASSACHUSETTS 02026 201-294-7644 DELAWARE CalypsoQ, LLC None Corporation true Thurein Htoo 770 Legacy Place 2nd Floor Dedham MA MASSACHUSETTS 02026 Executive Officer Director Andrew Danielson 200 First Street SW Rochester MN MINNESOTA 55905-0001 Director Adrienne Graves 770 Legacy Place 2nd Floor Dedham MA MASSACHUSETTS 02026 Director Ronald M. Hunt 156 Fifth Avenue Suite 820 New York NY NEW YORK 10010 Director Wende Hutton 2765 Sand Hill Road Menlo Park CA CALIFORNIA 94025 Director Barbara Wirostko 770 Legacy Place 2nd Floor Dedham MA MASSACHUSETTS 02026 Executive Officer Biotechnology Decline to Disclose 06b false 2025-11-13 false true true true Convertible Promissory Notes false 0 5641600 5641600 0 false 8 0 0 0 No amounts other than ordinary course employment compensation is being paid to officers and directors. false Qlaris Bio, Inc. Thurein Htoo Thurein Htoo Chief Executive Officer 2025-11-17